Relmada Therapeutics Inc (RLMD)

$ 0.57
   
  • Change Today:
    $-0.02
  • 52 Week High: $3.64
  • 52 Week Low: $0.26
  • Currency: US Dollars
  • Volume: 208,586
  • RiskGrade: 274

Financial Analysis

Select chart: EPS | Revenue

Key Fundamentals

Fundamentals data is not available for this company.

Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 n/a (60.60) (193.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-26 n/a (66.80) (170.00)¢ n/a n/a n/a n/a 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest n/a n/a n/a 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

RLMD Market Data

Currency US Dollars
Share Price $ 0.57
Change Today $ -0.02
% Change -3.37 %
52 Week High $3.64
52 Week Low $0.26
Volume 208,586
RiskGrade 274

What The Brokers Say

Strong Buy 0
Buy 0
Neutral 2
Sell 0
Strong Sell 0
Total 2
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 13-Aug-2025

Time Volume / Share Price
15:59 1,544 @ $0.56
15:59 456 @ $0.56
15:59 200 @ $0.57
15:53 200 @ $0.57
15:51 650 @ $0.57

Top of Page